ArticleBlood advances2020

Safety of venetoclax rapid dose escalation in CLL patients previously treated with B-cell receptor signaling antagonists.

Kristin L Koenig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.